Biogen and Eisai reported the finding from a large late-stage clinical trial of lecanemab, a drug they are developing.
Tag: Aduhelm (Drug)
-
Medicare Officially Limits Coverage of Aduhelm to Patients in Clinical Trials
Officials cited data showing the new Alzheimer’s drug has serious safety risks and may not help patients.
-
Inside a Campaign to Get Medicare Coverage for a New Alzheimer’s Drug
The Alzheimer’s Association has pushed relentlessly to get broad access to Aduhelm, despite safety risks and uncertain evidence that it helps patients.
-
F.D.A.’s Accelerated Drug Approvals Come Under Scrutiny
A drug to prevent preterm birth may provide the next test of the agency’s process for speedily getting drugs on the market, despite limited evidence that some work.